With two fully commercialised technologies proven at utility scale, complemented by an active New Product development pipeline, Bluewater Bio’s capabilities now include:
HYBACS® (enhanced activated sludge process)
FilterClear™ (high throughput multi-media filtration)
GHG-Tox® (nitrification & greenhouse gas monitoring)
NeoTech™ (highly efficient UV disinfection)
CFIC® (next-generation moving bed bioreactor (MBBR) technology)
Operational & Maintenance services (supporting a population equivalent of c. 1 million)
World Class R&D team, based at Cranfield University, UK
Bluewater Bio’s growing technology portfolio is focused primarily on the rapid upgrading, optimisation and monitoring of water and wastewater treatment plants. The company has a particular emphasis on reducing:
Capital, operational and compliance costs
Energy & chemical consumption
Physical & environmental footprint
Greenhouse gas emissions
Construction and commissioning times
Bluewater Bio not only develops its own innovations but also scours adjacent markets for complementary IP, licence opportunities and partnerships.